is an economic
consulting company that utilises leading
edge tools and approaches to assist investors,
researches and policy makers in a range of bio-science fields
eSYS Development has just commenced a study examining the extent of the fake drug problem in the Mekong region for the Asian Development Bank. Counterfeit medicines are deliberately and fraudulently mislabelled branded and generic products. The US based Centre for Medicines in the Public Interest predicts that counterfeit drug sales will reach US$ 75 billion globally in 2010, an increase of more than 90% from 2005. Regional and national estimates are hindered by the lack of a systematic evaluation of the problem.
